Print Page   |   Contact Us   |   Sign In   |   Join
News and Press: Member Organization News

Corium Close to Partnering on Transdermal Alzheimer’s Drug

Wednesday, November 29, 2017   (0 Comments)
Share |

Corium says it is in talks with commercialisation partners for its transdermal Alzheimer’s disease candisate Corplex Donepezil ahead of a potential 2019 launch.

Read article here.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal